Characterization of β-lactamases from urinary isolates of Escherichia coli in Tehran

Iranian Biomedical Journal

Volumn 11, Issue 2, 2007, Pages 95-99

  Hosseini Mazinani, Seyed Mehdi ^a   Eftekhar, Fereshteh ^b   Milani, Mahnaz ^b   Ghandili, Soheila ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

lactamase; Amp C; E. coli; SHV; TEM; Urinary

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CEFALEXIN; CEFALORIDINE; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIME; CEFRADINE; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CLAVULANIC ACID; EDETIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; OXACILLIN; PENICILLIN G; PENICILLINASE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIFFUSION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE AMPLIFICATION; HUMAN; HYDROLYSIS; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; UNIVERSITY HOSPITAL; URINALYSIS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA, BACTERIAL; ESCHERICHIA COLI; HUMANS; IRAN; LACTAMS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; URINE;

ESCHERICHIA COLI;

EID: 34249075479     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gonzalez, C.M. and Schaeffer, A.J. (1999) Treatment of urinary tract infection: what's old, what's new and what works? World J. Urol. 17: 372-382.
2. Gupta, K. (2003) Addressing antibiotic resistance. Dis. Mon. 49: 99-110.
3. Livermore, D.M. (1995) Beta-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584.
4. Bush, K. and Jacoby, G.A. (1997) Nomenclature of TEM β-lactamases. J. Antimicrob. Chemother. 39: 1-3.
5. Bush, K., Jacoby, G.A. and Medeiros, A.A. (1995) A functional classification scheme for β- lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39: 1211-1233.
6. Bush, K. (1989) Classification of β-lactamases: groups 1, 2a, 2b and 2b'. Antimirob. Agents Chemother. 33 (3): 264-270.
7. Bush, K. (1989) Classification of β-lactamases: groups 2c, 2d, 2e, 3 and 4. Antimirob. Agents Chemother. 33 (3): 271-276.
8. Barnaud, G., Labia, R., Raskine, L., Sanson-Le Pors, M.J., Philippon, A. and Arlet, G. (2001) Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195: 185-190.
9. Bradford, P.A. (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951.
10. Jacoby, G.A. and Medeiros, A.A. (1991) More extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 35: 1697-1704.
11. Pitout, J.D., Thomson, K.S., Hanson, N.D., Ehrhardt, A.F., Coudron, P. and Sanders, C.C. (1998) Plasmidmediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob. Agents Chemother. 42: 596-600.
12. Cudron, P.E., Moland, E.S. and Sanders, C.C. (1997) Occurrence and detection of extended spectrum β-lactamases in members of the family Enterobacteriaceae at a veteran's medical center: seek and you may find. J. Clin. Microbiol. 35 (10): 2593-2597.
13. Eftekhar, F., Hosseini-Mazinani, S.M., Ghandili, S., Hamraz, M. and Zamani, S. (2005) PCR detection of plasmid mediated TEM, SHV and AmpC β-lactamases in community and nosocomial urinary isolates of Escherichia coli. Iran. J. Biotechnol. 3 (1): 48-54.
14. Hosseini-Mazinani, S.M., Jafar-Nejad, H. and Ghandili, S. (2003) Beta-lactam resistance patterns of E. coli isolated from urinary tract infections at a major university hospital in Iran. J. Sci. Islam. Rep. Iran. 16: 209-212.
15. Hosseini-Mazinani, S.M., Nakajima, E., Ihara, Y., Kameyama, K.Z. and Sugimoto, K. (1996) Recovery of active β-lactamases from Proteus vulgaris and RTEM-1 hybrid by random mutagenesis by using dnaQ of Escherichia coli. Antimicrob. Agents Chemother. 40: 2152-2159.
16. National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disc susceptibility tests, seventh edition: approved standard M2-A7. NCCLS, Wayne, Pennsylvania, USA.
17. National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, fifth edition: approved standard M7-A5. NCCLS, Wayne, Pennsylvania, USA.
18. Ross, G.W. and O'Callaghan, C.H. (1975) β-lactamase assays. Methods Enzymol. 43: 68-85.
19. Winokur, P.L., Vonstein, D.L., Hoffman, L.G., Uhlenhopp, E.K. and Doren, G. (2001) Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food, animals and humans. Antimicrob. Agents Chemother. 45: 2716-2722.
20. Sutcliffe, J.G. (1978) Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA. 75: 3737-3741.
21. Kim, J., Kwon, Y., Pai, H., Kim, J.W. and Cho, D.T. (1998) Survey of Klebsiella pneumoniae strains producing extended spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36: 1446-1449.
22. Bret, L., Chanal-Claris, C., Sirot, D., Chaibi, E.B., Labia, R. and Sirot, J. (1998) chromosomally encoded ampC type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42: 1110-1114.
23. Mansouri, S. and Shareifi, S. (2002) Antimicrobial resistance pattern of Escherichia coli causing urinary tract infections and that of human fecal flora. Microb. Drug Resist. 8 (2): 123-128.
24. Samaha-Kfoury, N.J. and Araj, G.F. (2003) Recent developments in β-lactamases and extended spectrum β-lactamases. Brit. Med. J. 327: 1209-1213.